Latest Governance News

Plenti Group Limited has reported a fourth straight quarter of record loan originations, driving a 24% annual growth in its loan portfolio and doubling its half-year profits. The fintech lender is accelerating towards a $3 billion loan book target by March 2026 amid strong credit performance and strategic investments.

Great Divide Mining’s subsidiary has signed a binding term sheet with Native Mineral Resources to form a joint venture aimed at mining and processing gold ore from the Yellow Jack site, marking a key step towards production and cash flow.

Evolution Energy Minerals has fast-tracked its Chilalo Graphite Project in Tanzania, aiming to begin ore mining by late 2027 amid strong government partnership and advancing financing talks.

Basin Energy has confirmed substantial uranium mineralisation across three key projects in northern Sweden, validating historical data and positioning itself ahead of the anticipated lifting of Sweden's uranium exploration ban in 2026.

Vonex Limited has finalized its Scheme of Arrangement, transferring all shares to Maxo Telecommunications and initiating a board overhaul ahead of its imminent ASX delisting.

Alligator Energy Limited has released its comprehensive company constitution, detailing governance, shareholder rights, and director responsibilities under Australian law and ASX rules. This foundational document sets the framework for the company’s operations and compliance.

Aurumin Limited has obtained ASIC approval to extend its 2025 AGM deadline, aligning with the proposed acquisition by Brightstar Resources. This move sets the stage for a significant ownership change pending shareholder approval.

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.

Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.

Strategic Energy Resources (SER) has addressed recent unusual trading activity in its shares, attributing the price and volume spikes to external market factors while highlighting ongoing drilling projects in Queensland.

Ramsay Health Care announces a fully franked ordinary distribution of AUD 2.9642 per security on its perpetual preference shares, reflecting a steady income stream for investors. The payment is scheduled for April 2026, subject to board and external approvals.

United States Antimony Corporation has made a non-binding indicative offer to acquire Larvotto Resources at a significant premium, proposing a strategic merger focused on antimony supply chain security and growth.